Purdue Frederick pays out Texas portion of settlement in pain-killer case - St. Louis Business Journal:

bacijaxymu.wordpress.com
million from and its subsidiary as part of a nationaol settlement with stateMedicaid programs. The $1.6 millionm payment resolves Medicaid fraud investigations undertakemn by Texas Attorney General Greg Abbott relatexd tothe company's product OxyContin. Abbott'ws office claimed that Purdue misrepresented addictivr properties associated withits drug. Purdue marketed OxyContinj to Medicaid, physicians and patients as being less less susceptible to abuse and less likely to cause withdrawao problems than otherpain medications, accordinh to the state. Texas received a portiob of the funds fromthe company'se $130 million global settlement with state Medicaid programs.
Purdue has since taken steps to ensure that employees properly promote OxyContin tablets, including providing clear indications for its use in patients. "This agreementr ensures that physicians and patients are fully informed about the risks associated with Abbott says. "When Medicaid dollars are spent on falsely represented pharmaceutical it is critical that the taxpayers are reimbursed fortheir losses." Purdue is a Stamford, Conn.-based pharmaceutica l company specializing in pain treatment.
The companyg develops both prescriptionand over-the-counter druge and continues to market